Foghorn Therapeutics (FHTX) Metrics: History & Chart

Foghorn Therapeutics Inc.(FHTX)

Biotechnology · Watertown, MA

$1.96-0.04 (-2.00%)

Delayed quote: Oct 6, 2026, 12:00 PM EDT

About Foghorn Therapeutics Inc.

Foghorn Therapeutics Inc. is a clinical-stage biopharmaceutical company dedicated to discovering and developing medicines. Their focus is on addressing genetically determined vulnerabilities within the chromatin regulatory system. The company employs its exclusive "Gene Traffic Control" platform to pinpoint, validate, and strategize drug development for specific targets within this complex system. Its pipeline includes FHD-286, a small-molecule agent engineered to halt the enzymatic activity of BRG1 and BRM. This compound is being developed to treat metastatic uveal melanoma, as well as acute myeloid leukemia and myelodysplastic syndrome that have either recurred or are resistant to previous therapies. Another key candidate, FHD-609, is a small-molecule protein degrader designed to target BRD9, intended for patients diagnosed with synovial sarcoma. Beyond these, Foghorn is also further developing a selective enzymatic inhibitor and a protein degrader, both designed to modulate BRM. Additionally, they are working on ARID1B selective modulators, with potential applications in treating ovarian, endometrial, colorectal, bladder, and gastric cancers. The company has forged strategic alliances, including a research collaboration and licensing agreement with Merck Sharp & Dohme Corp. aimed at unearthing and creating novel oncology therapies focused on a transcription factor target. They also collaborate with Loxo Oncology to devise new cancer treatments. Foghorn Therapeutics Inc. was established in 2015 and maintains its headquarters in Cambridge, Massachusetts.

Watertown, MA

106 employees

foghorntx.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Adrian H. Gottschalk

View full financials

Third-Party DCF Estimate (FMP)	N/A
Price Gap vs Third-Party Estimate	N/A

7D Total Return	-43.18%
30D Total Return	-59.35%
YTD Total Return	-62.96%
1Y Total Return	-56.90%
3Y Total Return	-52.94%
5Y Total Return	-85.32%
10Y Total Return	N/A
15Y Total Return	N/A
20Y Total Return	N/A

2026	-62.96%
2025	+14.41%
2024	-26.82%
2023	+1.10%
2022	-72.10%
2021	+12.83%
2020

CAGR TTM	-56.72%
CAGR 3Y	-22.21%
CAGR 5Y	-31.87%
CAGR 10Y	N/A
CAGR 15Y	N/A
CAGR 20Y	N/A

PE Ratio	N/A
PE Ratio Avg TTM	N/A
PE Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

All Metrics

FHTX Valuation Metrics

FHTX Stock Price Metrics

FHTX Dividend Metrics

FHTX Growth Rate Metrics

FHTX Discounted Cash Flow Metrics

FHTX Returns By Period

FHTX Yearly Returns

FHTX Average Annual Returns By Period (CAGR)

FHTX Revenue Metrics

FHTX PE Ratio Metrics

FHTX PS Ratio Metrics

FHTX PB Ratio Metrics

FHTX Price to Free Cash Flow Ratio Metrics

FHTX Debt to Equity Ratio Metrics

FHTX PEG Ratio Metrics

FHTX FCF Yield

FHTX Earnings Yield

FHTX EBITDA Yield

FHTX OCF Yield

FHTX EV/EBIT Ratio Metrics

FHTX EV/EBITDA Ratio Metrics

FHTX EV/Assets Ratio Metrics

FHTX EV/Sales Ratio Metrics

FHTX Current Ratio Metrics

FHTX Quick Ratio Metrics

FHTX ROIC Metrics

FHTX Return on Assets Metrics

FHTX Return on Equity Metrics

FHTX Net Profit Margin Metrics

FHTX Gross Profit Margin Metrics

FHTX Tax Rate Metrics

PS Ratio	3.84
PS Ratio Avg TTM	11.60
PS Ratio Avg 3Y	10.65
Current VS TTM Avg	-66.89%
Current VS 3Y Avg	-63.94%
Current VS 5Y Avg	-68.10%

PB Ratio	2026.72
PB Ratio Avg TTM	9.70
PB Ratio Avg 3Y	6.77
Current VS TTM Avg	+20799.25%
Current VS 3Y Avg	+29853.15%
Current VS 5Y Avg	+29853.15%

PFCF Ratio	1.18
PFCF Ratio Avg TTM	1.66
PFCF Ratio Avg 3Y	1.66
Current VS TTM Avg	-28.70%
Current VS 3Y Avg	-28.70%
Current VS 5Y Avg	-28.70%

Debt/Equity Ratio	(0.53)
Debt/Equity Ratio Avg TTM	(0.40)
Debt/Equity Ratio Avg 3Y	(0.63)
Current VS TTM Avg	-31.50%
Current VS 3Y Avg	+16.03%
Current VS 5Y Avg	-77.50%

PEG Ratio	N/A
PEG Ratio Avg TTM	N/A
PEG Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

FCF Yield	84.76%
FCF Yield Avg TTM	66.13%
FCF Yield Avg 3Y	66.13%
Current VS TTM Avg	+28.17%
Current VS 3Y Avg	+28.17%
Current VS 5Y Avg	+28.17%

Earnings Yield	N/A
Earnings Yield Avg TTM	N/A
Earnings Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

EBITDA Yield	N/A
EBITDA Yield Avg TTM	N/A
EBITDA Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

OCF Yield	N/A
OCF Yield Avg TTM	N/A
OCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebit Ratio	N/A
Ev/Ebit Ratio Avg TTM	N/A
Ev/Ebit Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebitda Ratio	N/A
Ev/Ebitda Ratio Avg TTM	N/A
Ev/Ebitda Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Assets Ratio	0.57
Ev/Assets Ratio Avg TTM	1.25
Ev/Assets Ratio Avg 3Y	1.01
Current VS TTM Avg	-54.41%
Current VS 3Y Avg	-43.47%
Current VS 5Y Avg	-39.70%

Ev/Sales Ratio	3.17
Ev/Sales Ratio Avg TTM	9.76
Ev/Sales Ratio Avg 3Y	9.07
Current VS TTM Avg	-67.51%
Current VS 3Y Avg	-65.06%
Current VS 5Y Avg	-70.64%

Current Ratio	3.36
Current Ratio Avg TTM	2.76
Current Ratio Avg 3Y	3.81
Current VS TTM Avg	+21.82%
Current VS 3Y Avg	-11.81%
Current VS 5Y Avg	-36.07%

Quick Ratio	3.36
Quick Ratio Avg TTM	2.76
Quick Ratio Avg 3Y	3.81
Current VS TTM Avg	+21.82%
Current VS 3Y Avg	-11.81%
Current VS 5Y Avg	-36.07%

ROIC	(44.81%)
ROIC Avg 3Y	(48.21%)
ROIC Avg 5Y	(44.10%)
Current VS 3Y Avg	+7.06%
Current VS 5Y Avg	-1.62%
Current VS 10Y Avg	-0.93%

ROA	(31.75%)
ROA Avg TTM	(7.82%)
ROA Avg 3Y	(7.87%)
Current VS TTM Avg	-306.24%
Current VS 3Y Avg	-303.66%
Current VS 5Y Avg	-330.95%

ROE	N/A
ROE Avg TTM	(208.64%)
ROE Avg 3Y	(172.75%)
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Net Profit Margin	(175.78%)
Net Profit Margin Avg TTM	(263.82%)
Net Profit Margin Avg 3Y	(339.91%)
Current VS TTM Avg	+33.37%
Current VS 3Y Avg	+48.29%
Current VS 5Y Avg	+57.05%

Gross Profit Margin	89.22%
Gross Pft Margin Avg TTM	45.36%
Gross Pft Margin Avg 3Y	95.74%
Current VS TTM Avg	+96.69%
Current VS 3Y Avg	-6.81%
Current VS 5Y Avg	+211.19%

Tax Rate	0.00%
Tax Rate Avg 3Y	(1.12%)
Tax Rate Avg 5Y	(0.75%)
Current VS 3Y Avg	+100.00%
Current VS 5Y Avg	+100.00%
Current VS 10Y Avg	+100.00%